Literature DB >> 17161543

Characterization of acetylcholine release and the compensatory contribution of non-Ca(v)2.1 channels at motor nerve terminals of leaner Ca(v)2.1-mutant mice.

S Kaja1, R C G van de Ven, L A M Broos, R R Frants, M D Ferrari, A M J M van den Maagdenberg, J J Plomp.   

Abstract

The severely ataxic and epileptic mouse leaner (Ln) carries a natural splice site mutation in Cacna1a, leading to a C-terminal truncation of the encoded Ca(v)2.1 alpha(1) protein. Ca(v)2.1 is a neuronal Ca(2+) channel, mediating neurotransmitter release at many central synapses and the peripheral neuromuscular junction (NMJ). With electrophysiological analyses we demonstrate severely reduced ( approximately 50%) neurotransmitter release at Ln NMJs. This equals the reduction at NMJs of Cacna1a null-mutant (Ca(v)2.1-KO) mice, which display a neurological phenotype remarkably similar to that of Ln mice. However, using selective Ca(v) channel blocking compounds we revealed a compensatory contribution profile of non-Ca(v)2.1 type channels at Ln NMJs that differs completely from that at Ca(v)2.1-KO NMJs. Our data indicate that the residual function and presence of Ln-mutated Ca(v)2.1 channels precludes presynaptic compensatory recruitment of Ca(v)1 and Ca(v)2.2 channels, and hampers that of Ca(v)2.3 channels. This is the first report directly showing at single synapses the deficits and plasticity in transmitter release resulting from the Ln mutation of Cacna1a.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161543     DOI: 10.1016/j.neuroscience.2006.11.006

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse.

Authors:  Samuel W Cramer; Laurentiu S Popa; Russell E Carter; Gang Chen; Timothy J Ebner
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

2.  Age-dependent contribution of P/Q- and R-type Ca2+ channels to neuromuscular transmission in lethargic mice.

Authors:  Elizabeth Molina-Campos; Youfen Xu; William D Atchison
Journal:  J Pharmacol Exp Ther       Date:  2014-12-03       Impact factor: 4.030

Review 3.  Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy.

Authors:  Darlene S Douglas; Brian Popko
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

4.  Concurrent Lpin1 and Nrcam mouse mutations result in severe peripheral neuropathy with transitory hindlimb paralysis.

Authors:  Darlene S Douglas; Jennifer L Moran; John R Bermingham; Xiang-Jun Chen; David N Brindley; Betty Soliven; David R Beier; Brian Popko
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

Review 5.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

6.  Purkinje cell-specific ablation of Cav2.1 channels is sufficient to cause cerebellar ataxia in mice.

Authors:  Boyan Todorov; Lieke Kros; Reinald Shyti; Petra Plak; Elize D Haasdijk; Robert S Raike; Rune R Frants; Ellen J Hess; Freek E Hoebeek; Chris I De Zeeuw; Arn M J M van den Maagdenberg
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

7.  Ablation of Ca(V)2.1 voltage-gated Ca²⁺ channels in mouse forebrain generates multiple cognitive impairments.

Authors:  Robert Theodor Mallmann; Claudio Elgueta; Faten Sleman; Jan Castonguay; Thomas Wilmes; Arn van den Maagdenberg; Norbert Klugbauer
Journal:  PLoS One       Date:  2013-10-31       Impact factor: 3.240

Review 8.  Calcium channelopathies and intellectual disability: a systematic review.

Authors:  Miriam Kessi; Baiyu Chen; Jing Peng; Fangling Yan; Lifen Yang; Fei Yin
Journal:  Orphanet J Rare Dis       Date:  2021-05-13       Impact factor: 4.123

Review 9.  The ataxic Cacna1a-mutant mouse rolling nagoya: an overview of neuromorphological and electrophysiological findings.

Authors:  Jaap J Plomp; Arn M J M van den Maagdenberg; Simon Kaja
Journal:  Cerebellum       Date:  2009-05-30       Impact factor: 3.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.